$1.160
-0.029 (-2.52%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de MIST por análisis de gráficos similares
Alphio's MIST stock price prediction model matches the current Milestone Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.14 (-1.83%). The 1-week path is $1.13 (-2.18%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Milestone Pharmaceuticals Inc?
Milestone Pharmaceuticals Inc is a good buy right now due to its recent positive developments, including a pivotal Phase 3 trial initiation for etripamil, which could significantly enhance its market position. The stock is currently priced at $1.16, and analysts have set a price target of $3, indicating a potential upside of over 150%. Additionally, the company reported a significant increase in prescriptions for its product, with Q2 2026 revenue reaching $559,000, a notable improvement from previous quarters. However, the main risk is the ongoing net losses, with a reported loss of $28.6 million in Q2 2026, which could impact future performance if not addressed.
MIST cerró en $1.16 el Friday, tras bajar -2.52%
Milestone Pharmaceuticals Inc (MIST) last closed at $1.16, losing -2.52%. These facts feed the 1-day and 1-week MIST price prediction above.
Factores de la previsión
Los factores de la previsión de Milestone Pharmaceuticals Inc (MIST) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de MIST, ordenadas por similitud.
Análisis de estacionalidad de MIST
Historically the probability of a positive August return for MIST is 0.00%. December offers the highest probability of a positive month at 65.12%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de MIST
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $1.21 | $1.55 | $1.78 | +33.71% |
| Sep 2026 | $1.66 | $1.84 | $1.87 | +58.66% |
| Oct 2026 | $1.73 | $1.91 | $2.16 | +64.47% |
| Nov 2026 | $1.71 | $1.91 | $2.16 | +64.47% |
| Dec 2026 | $1.71 | $1.89 | $2.13 | +62.73% |
En 2026, se proyecta que Milestone Pharmaceuticals Inc (MIST) oscile entre $1.21 y $2.16.
Previsión mensual de Milestone Pharmaceuticals Inc para 2026
En Aug de 2026, se proyecta que Milestone Pharmaceuticals Inc promedie $1.55, con un mínimo de $1.21 y un máximo de $1.78.
En Sep de 2026, se proyecta que Milestone Pharmaceuticals Inc promedie $1.84, con un mínimo de $1.66 y un máximo de $1.87.
En Oct de 2026, se proyecta que Milestone Pharmaceuticals Inc promedie $1.91, con un mínimo de $1.73 y un máximo de $2.16.
En Nov de 2026, se proyecta que Milestone Pharmaceuticals Inc promedie $1.91, con un mínimo de $1.71 y un máximo de $2.16.
En Dec de 2026, se proyecta que Milestone Pharmaceuticals Inc promedie $1.89, con un mínimo de $1.71 y un máximo de $2.13.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.